US equities
|
SPCX
$173.84
▲+1.61%
NVDA
$241.84
▲+1.23%
MU
$1,073.39
▲+0.89%
MRVL
$296.12
▲+9.17%
AMD
$643.95
▲+1.93%
SNDK
$1,690.99
▼-0.77%
TSLA
$380.30
▲+0.41%
META
$738.69
▼-0.43%
SPCX
$173.84
▲+1.61%
NVDA
$241.84
▲+1.23%
MU
$1,073.39
▲+0.89%
MRVL
$296.12
▲+9.17%
AMD
$643.95
▲+1.93%
SNDK
$1,690.99
▼-0.77%
TSLA
$380.30
▲+0.41%
META
$738.69
▼-0.43%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:KNSA
Recent news which mentions NASDAQ:KNSA
KNSA Stock Earnings: Kiniksa Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
July 23, 2024
Tickers
KNSA
Tags
NASDAQ:KNSA
Market News
KNSA
From
InvestorPlace
Sector Spotlight: Orphan Drug Developers With Significant Upside
June 03, 2024
Tickers
CRDL
CRDL
KNSA
Tags
NASDAQ:CRDL
NASDAQ:KNSA
From
News Direct
KNSA Stock Earnings: Kiniksa Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
April 23, 2024
Tickers
KNSA
Tags
NASDAQ:KNSA
Market News
KNSA
From
InvestorPlace